Sandbox g12: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) (Created page with " * Torsades de pointes risk stratification schedules for antimicrobial agents :* '''Schedule I (Highest TdP risk, potent IKr blockers, TdP risk >1%)''' ::* Not available :...") |
Gerald Chi- (talk | contribs) mNo edit summary |
||
| Line 2: | Line 2: | ||
<ref>{{cite web | title = Arizona Center for Education and Research on Therapeutics | url = http://www.torsades.org }}</ref> | |||
* Torsades de pointes risk stratification schedules for antimicrobial agents | * Torsades de pointes risk stratification schedules for antimicrobial agents | ||
Revision as of 21:20, 31 May 2015
- Torsades de pointes risk stratification schedules for antimicrobial agents
- Schedule I (Highest TdP risk, potent IKr blockers, TdP risk >1%)
- Not available
- Schedule II (Significant risk for TdP, particularly when coadministered with CYP inhibitors, relatively potent IKr blockade)
- Not available
- Schedule III (Risk for TdP is described, IKr blockade, particularly when coadministered with CYP inhibitors)
- Schedule IV (Minimal risk for TdP, case reports of TdP, mild IKr blockade, may have CYP interactions)
- Schedule V (Questionable/minimal risk for QT interval prolongation/TdP)